A lot of people arrive with an old photo saved on their phone, a firm lump they can feel in the cheek, and no clear answer when I ask what was injected. "I forgot." "The last doctor never really explained." "Hyaluronic acid, maybe?"
The thing is, what that lump is made of decides whether it can be dissolved, whether it needs to be removed, and how. Rushing to inject hyaluronidase, inject steroid, or cut before you can see what you are dealing with usually wastes the effort. Reading the material comes first. Only then can you talk about repair.
Why identifying the material matters more than rushing to treat it
Not every filler answers to the same move. HA (hyaluronic acid, the water-holding sugar molecule skin already contains) can in theory be dissolved with hyaluronidase. But CaHA (calcium hydroxylapatite, the active ingredient in Radiesse), PLLA (poly-L-lactic acid, the ingredient in Sculptra), PCL (polycaprolactone, the ingredient in Ellansé), and permanent materials like silicone don't budge for hyaluronidase at all. They can only be physically removed.
So material identification isn't academic curiosity. It's a fork in the road. Get it wrong and the whole direction is wrong. That's why our filler repair clinic always images first and discusses treatment second.
Ultrasound earns this role because it's currently the only imaging tool that can detect and identify these subcutaneous foreign materials without cutting (Wortsman, 2015).
Key insight: Identifying the material isn't about satisfying curiosity. It's the fork that decides "dissolve or extract." Only HA responds to hyaluronidase; blindly injecting it into other materials usually just delays things.
How ultrasound reads a filler: three axes plus one key fingerprint
When I look at a scan, I read three things, then one feature that often settles it.
First, how bright the echo is. Sound waves bounce back wherever tissue density changes. Materials high in water and loose in structure look dark (hypoechoic to anechoic), like HA. Materials dense with mineral or particles look bright (hyperechoic), like CaHA.
Second, how defined the margin is. Freshly injected HA often sits as separate, well-bordered pockets. After it integrates into tissue, or once a fibrous capsule forms, the margin blurs.
Third, what happens behind the deposit. Sound waves passing through a calcified mass get blocked, casting a dark band behind it — that's posterior acoustic shadowing. Pass through clear fluid and the opposite happens: it looks brighter behind (posterior enhancement).
The last piece is the artifact, the near-exclusive pattern certain materials leave on the image. Silicone's snowstorm, PCL's mini comet-tail, the posterior shadow of calcified materials — these are fingerprints. Recognising them is more reliable than reading brightness alone.
Six fillers on ultrasound: a side-by-side comparison chart
Put the six common material families side by side and the differences surface. This chart draws on clinical imaging literature and on what we see during our own extractions:
← Swipe to see more →
| Material family | Echogenicity | Margin | Posterior / signature artifact | Over time | Hyaluronidase works? |
|---|---|---|---|---|---|
| Hyaluronic acid (HA) | Hypoechoic to anechoic (dark) | Globular and well-defined when fresh; heterogeneous once integrated | Usually posterior enhancement (transmits sound well) | Resorbs gradually; some encapsulate and harden | Yes (poor if encapsulated) |
| Poly-L-lactic acid (PLLA) | Weak signal, often hyperechoic but hard to read | Diffuse, no clear shape | No exclusive artifact; usually surrounding fibrosis (hyperechoic) | Resorbs fast, often nearly invisible | No |
| Polycaprolactone (PCL) | Multiple bright spots in a hypoechoic matrix | Moderate | Mini comet-tail (signature fingerprint) | Persists for years | No |
| Calcium hydroxylapatite (CaHA) | Hyperechoic | Mass-like | Posterior shadowing / coarse snowfall pattern | Resorbs gradually | No |
| Silicone / PMMA (permanent) | Hyperechoic, spread through the layer | Diffuse | Silicone = fine snowfall + posterior reverberation; PMMA = coarse snowfall | Does not resorb (permanent) | No |
| Autologous fat | Hypo- to isoechoic, lobular | Resembles subcutaneous fat | Egg-shell hyperechoic + posterior shadow when calcified or oil-cyst | Partly survives, partly calcifies/necroses | No |
A few studies help explain where this chart comes from. Urdiales-Gálvez and colleagues sorted filler appearances into four patterns in 2021: well-integrated HA looks "heterogeneous," silicone is "fine-grain snowfall with posterior echogenic shadows," CaHA and PMMA are "coarse-grain snowfall," and polyacrylamides — along with freshly injected HA — appear "globular and cystic" (Urdiales-Gálvez et al., 2021). PCL's mini comet-tail was specifically described by Wortsman and Quezada in 2017, and it's one of the best ways to set it apart from other materials (Wortsman & Quezada, 2017).
If you want a more systematic look at how ultrasound forms these images and what each material looks like item by item, read the overview on the imaging science of identifying filler types.
Key insight: What's genuinely useful isn't a single axis like bright-or-dark. It's the exclusive artifact — silicone's snowstorm, PCL's comet-tail, the posterior shadow of calcified materials — that best tells the materials apart.
The three pairs most easily confused (let me be honest here)
The chart looks clean, but a few pairs overlap in practice. Saying so is more responsible than insisting ultrasound always tells them apart.
First pair: freshly injected HA and polyacrylamide (PAAG, polyacrylamide, an older permanent hydrogel). Both can appear as round, anechoic, cystic structures. The difference often isn't in the image at all but in the history — one resorbs slowly, the other is still there a decade later.
Second pair: CaHA and PMMA. Both show coarse-grain snowfall and run hyperechoic, and the pattern alone rarely settles it. Here you weigh injection date, product records, and the degree of posterior shadowing together.
The third "pair" is really "barely visible." PLLA resorbs quickly, and by the time many people come in for a scan the signal is faint, with no clear mass on the image. What speaks instead is the ring of fibrosis around it. In that situation, history and palpation carry more weight than the picture.
People with an unknown material who may have mixed several over the years are the hardest group. We covered that separately in how to identify an unknown filler, which looks at the clues beyond imaging.
Ultrasound isn't a 100% confirmatory test: what it can and can't do
I want to draw this line clearly. What ultrasound can do is narrow the field a great deal, turning "no idea" into "most likely this class, in this treatment lane." What it can't do is hand you a 100% composition report the way a lab assay would.
The image is shaped by operator experience, machine frequency, time since injection, and whether materials were mixed. So we never treat a single image as the verdict. We cross-check imaging, history and palpation. If they line up, we move on to an extraction plan. If they don't, we'd rather gather more information than act on a guess. That's also why complications from collagen-stimulating materials deserve more careful assessment.
Different imaging features, different extraction strategies
Identifying the material isn't the finish line. It's the start. How a material looks on ultrasound directly rewrites how we remove it through a single pinhole.
For encapsulated HA, the point is to first trace the fibrous capsule's border on ultrasound, then go in along that border and take the whole package, capsule included — not just suction out the soft center and leave the hard shell to keep causing trouble. For a calcified material like CaHA with obvious posterior shadowing, imaging locks down the location and depth of the calcified mass so we can take it precisely while avoiding vessels and nerves. For PCL, with its scattered bright spots and mini comet-tail, imaging frames the distribution, because it isn't one large ball but several scattered deposits.
This is what we mean by "you have to see it to treat it safely." Operate without a clear view and you're relying on luck. See it clearly first and you're relying on a plan.
Frequently Asked Questions
I genuinely don't remember what was injected. Can ultrasound really tell?
In most cases it can narrow things to a class, and judge whether it falls in the "dissolvable" or "physical extraction" lane. But pinning it to a brand or confirming the exact composition is beyond imaging alone — that needs history, injection records and palpation read together. When the material is truly uncertain, we treat that as a reason to assess more carefully, not to proceed.
If ultrasound says I have HA, can it always be dissolved with hyaluronidase?
Not necessarily. HA is indeed the only material that responds to hyaluronidase, but if it's already wrapped in fibrous tissue (encapsulated), the enzyme struggles to reach the core, and people often still feel a lump after several sessions. In that case the image shows a clear encapsulating border, and the approach shifts from "dissolve" to "physical extraction along the border."
Why are some fillers almost invisible on ultrasound?
The classic example is PLLA. It resorbs relatively fast, so by the time of imaging the material's own signal may already be weak, and it's the fibrosis it stimulated that shows up as hyperechoic. In that situation, reading leans more on history and palpation than on the image alone.
CaHA and PMMA both look like coarse snowfall — how do you confirm which one?
The pattern alone makes it genuinely hard; both run coarse-grain snowfall and hyperechoic. In practice you compare injection date, product records, the degree of posterior shadowing, and whether the material resorbs over time. CaHA resorbs gradually while PMMA is permanent, and that time difference is an important clue.
I may have had several materials in the same spot — can ultrasound still separate them?
Mixed materials are the most complex case, with patterns that can overlap. An experienced operator can usually pick out the features of a few dominant components, but fully resolving every layer gets markedly harder. This is exactly why people with an unknown, likely-mixed history need assessment by a doctor familiar with repair.
Once the material is identified, what's the next step?
Identification is where planning begins. Once we confirm whether the material is dissolvable or needs physical extraction, we use ultrasound to map depth, distribution, and its relationship to vessels and nerves, and design a single-pinhole extraction path from there. If you're stuck not knowing what's in your face or who should handle it, you're welcome to book an assessment with Dr. Ta-Ju Liu — let's see the material clearly first, then talk about how to repair it.
This article is educational information, not individual medical advice. Actual filler identification and treatment must be decided after in-person consultation and imaging assessment; the use of medications such as hyaluronidase requires evaluation by a physician.
